Great Point Partners’s Esperion Therapeutics ESPR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-5,791,594	Closed	-$12.9M	–	31
2024 Q2	$12.9M	Sell	5,791,594 -2,208,406	-28%	-$4.9M	2.46%	18
2024 Q1	$21.4M	Buy	+8,000,000	New	+$21.4M	3.34%	11
2015 Q3	–	Sell	-8,400	Closed	-$687K	–	35
2015 Q2	$687K	Buy	+8,400	New	+$687K	0.27%	29